Avastin Supply Chain Slip Lands U.S. Physicians FDA Scolding

The FDA has sent letters to physicians in 12 U.S. states, including nearly 30 in California, requesting they cease using and secure all products from a foreign distributor known for selling unapproved and counterfeit drugs, such as fake Avastin. The physicians are accused of purchasing medications from Richards Pharma, which has distributed unapproved products, including a counterfeit version of Roche’s Altuzan, the brand name of Turkish Avastin (bevacizumab). The counterfeit drug, lot no. B6201, contained no active ingredient. 
Washington Drug Letter